QUALITY CHOICE

Manufacturer
QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)
Effective date
2025-10-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:15:30

Label at a glance#

ProductQUALITY CHOICE Nausea Relief
Active ingredientTRISODIUM CITRATE DIHYDRATE
Label structure15 sections

Indications and uses

For the relief of nausea associated with upset/sour stomach, including that due to overindulgence in food and drink.

Dosage and administration

Adults : 2-4 tablets. Children : Consult a doctor for appropriate dosage. Chew tablets completely. Do not swallow tablet whole. Dosage may be repeated after 15 minutes, not to exceed 24 tablets in a 24-hour period unless advised by a doctor. Read all package directions and warnings before use and use only as directed. These tablets are intended for use by normally healthy persons only. Persons under 18 years of ag...

Label contents#

Full prescribing information#

Active ingredient (in each chewable tablet)

OTC - ACTIVE INGREDIENT SECTION

Sodium citrate dihydrate 230 mg

Purpose

OTC - PURPOSE SECTION

Upset stomach reliever

Uses

INDICATIONS & USAGE SECTION

For the relief of nausea associated with upset/sour stomach, including that due to overindulgence in food and drink.

OTC - DO NOT USE SECTION

Do not useif you

  • have Hereditary Fructose Intolerance (HFI).  This product contains fructose.

Ask a doctor before use if you

OTC - ASK DOCTOR SECTION

  • have diabetes because this product contains sugar
  • are on a sodium-restricted diet

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you aretaking any other medications. This product may interact with certain prescription drugs.

OTC - WHEN USING SECTION

When using this product,do not take more than 24 tablets in a 24-hour period.

OTC - STOP USE SECTION

Stop use and ask a doctor ifnausea lasts more than two weeks or recurs frequently.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding,ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Adults: 2-4 tablets.
  • Children: Consult a doctor for appropriate dosage.
  • Chew tablets completely. Do not swallow tablet whole.
  • Dosage may be repeated after 15 minutes, not to exceed 24 tablets in a 24-hour period unless advised by a doctor.
  • Read all package directions and warnings before use and use only as directed.
  • These tablets are intended for use by normally healthy persons only.
  • Persons under 18 years of age should use only as directed by a doctor.

Other information

SPL UNCLASSIFIED SECTION

  • Each tablet contains:sodium 60 mg
  • Store at room temperature.
  • Protect product from excessive heat, cold and moisture.
  • Note:  This product is not intended as a substitute for a balanced nutritional diet or as an electrolyte replenishment.
  • You may report serious side effects to the phone number provided under Questions?

Inactive ingredients

INACTIVE INGREDIENT SECTION

dextrose, FDC Red No. 40, flavors, fructose, hydroxypropyl cellulose, magnesium stearate, maltodextrin, silica, sodium carboxymethylcellulose, sucralose.

Questions

OTC - QUESTIONS SECTION

1-866-467-2748

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Quality Choice®

*Compare to the Active Ingredient in Nauzene® Tablets

NDC# 83324-300-42

Nausea Relief

For upset stomach & nausea

With electrolyte**

Free From:

Gluten, Aspartame

Aspirin and Salicylate

Wild Cherry Flavor

Naturally & Artificially Flavored

42 CHEWABLE TABLETS

TAMPER EVIDENT: DO NOT USE IF PRINTED SEAL UNDER CAP IS BROKEN OR MISSING

IMPORTANT: Keep this carton for future reference on full labeling

Distributed by: CDMA, Inc.

Novi, MI 48375

Questions: 800-935-2362

100% SATISFACTION GUARANTEED

*This product is not manufactured of distributed by ALVA-AMCO Pharmacal Cos., Inc., the distributor of Nauzene® Tablets.

**Sodium citrate dihydrate

Quality Choice Nausea Relief 42 Chewable Tablets
Quality Choice Nausea Relief 42 Chewable Tablets

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2002800sodium citrate 230 MG Chewable TabletPSN1
2002800sodium citrate 230 MG Chewable TabletSCD1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ANHYDROUS CITRIC ACID Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83324-300-42QUALITY CHOICENausea Relief3 in 1 CARTONTABLET, CHEWABLE31
83324-300-42QUALITY CHOICENausea Relief14 in 1 BLISTER PACKTABLET, CHEWABLE141

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83324-30083324-300-42

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
QUALITY CHOICE Nausea ReliefSODIUM CITRATE DIHYDRATEQUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)d89e41c1-399a-4157-8d54-bfefe3b1c1cd2025-10-01WarningsExact identifier
ndc (package): 83324-300-42
ndc (product): 83324-300
ndc11 (package): 83324030042
spl id: 401c4d5c-7ff4-3f9d-e063-6294a90ad71e
spl set id: d89e41c1-399a-4157-8d54-bfefe3b1c1cd

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.